Pancreatic and hepatobiliary cancers: Adjuvant therapy and management of inoperable disease

Annals of Oncology

Volumn 11, Issue SUPPL. 3, 2000, Pages 153-159

  Glimelius, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ANALGESIA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESPONSE; ENDOSCOPIC THERAPY; HEPATOBILIARY SYSTEM CANCER; HUMAN; NAUSEA; OBSTRUCTIVE JAUNDICE; PALLIATIVE THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; RADIOSURGERY; STENT; STEREOTAXIC SURGERY; STOMACH OBSTRUCTION; VOMITING;

BILIARY TRACT NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMAN; LIVER NEOPLASMS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 0033778515     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011132100248     Document Type: Conference Paper

References (61)

1. Cancer of the pancreas: 50 years of surgery
2. Cancer survival in Sweden during three decades: 1961-1991
3. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors
4. Epidemiology of hepatocellular carcinoma
5. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas
6. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial
7. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice
8. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction
9. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer
10. Surgical palliation for pancreatic cancer: Developments during the past two decades
11. Gastrojejunostomy: Is it helpful for patients with pancreatic cancer?
12. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients
13. Role of endoscopic stenting in the duodenum
14. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain?
15. Thoracoscopic splanchnicectomy for chronic, severe pancreatic pain
16. Surgical palliative treatment in bilio-pancreatic malignancy
17. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: Results of a controlled, prospective, randomized multicenter study
18. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreaticbiliary carcinomas
19. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
20. Radiotherapy and 5-FU after curative resection for cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC and GITCCG
21. ESPAC-1 interim results: A European randomised study to assess the roles of adjuvant chemotherapy (5FU + folinic acid) and adjuvant chemoradiation (40 Gy + 5FU) in resectable pancreatic cancer
22. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection for pancreatic cancer
23. Adjuvant therapy for pancreatic cancer: Back to the future
24. Survival after combined modality therapy for pancreatic cancer
25. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5-fluorouracil
26. 3rd. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study
27. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma
28. Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer
29. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels
30. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
31. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head
32. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
33. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group
34. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
35. Radiation therapy combined with adriamycin or 5-Fluorouracil for the treatment of locally unresectable pancreatic carcinoma
36. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study
37. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas
38. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: Results of a feasability study
39. Radiotherapy of unresectable pancreatic carcinoma: A six year experience with 104 patients
40. Pancreas and hepatobiliary tract
41. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers
42. Carcinoma of the extrahepatic bile ducts: The University of California at San Francisco experience
43. The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancer
44. External radiotherapy and extrahepatic bile duct cancer
45. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma
46. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival
47. The linear-quadratic formula and progress in fractionated radiotherapy
48. Clinical experiences with intraoperative radiotherapy of locally advanced cancers
49. Conformal irradiation for hepatobiliary malignancies
50. Studies of intraoperative radiotherapy in carcinoma of the pancreas
51. Future role of radiotherapy as a component of treatment in biliopancreatic cancers
52. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: Correlations of a clinical trial
53. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma
54. Primarry hepatic malignancy: Surgical management and determinants of survival
55. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
56. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: Results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial
57. Ultrasound-guided percutaneous alcohol injection of small liver metastases
58. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
59. Cryosurgery for hepatic malignancies
60. Radiosurgery for tumors in the body: Clinical experience using a new method
61. Objective responses after fractionated infusional brachytherapy of unresectable pancreatic adenocarcinomas